Meeting
2023 ASCO Annual Meeting
Prognostic value of liver metastases in colorectal cancer treated by systemic therapy: An ARCAD pooled analysis.
Authors
Romain Cohen
Sorbonne University, Department of Medical Oncology, Saint-Antoine Hospital, AP-HP, Paris, France
Romain Cohen , Morteza Raeisi , Qian Shi , Benoist Chibaudel , Takayuki Yoshino , John Raymond Zalcberg , Richard Adams , Chiara Cremolini , Eric Van Cutsem , Volker Heinemann , Josep Tabernero , Cornelis J. A. Punt , Dirk Arnold , Herbert I. Hurwitz , Jean-Yves Douillard , Alan P. Venook , Leonard B. Saltz , Timothy S. Maughan , Thierry Andre , Aimery De Gramont
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal Cancer—Colorectal and Anal
Track
Gastrointestinal Cancer—Colorectal and Anal
Sub Track
Colorectal Cancer–Advanced Disease
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 3554)
DOI
10.1200/JCO.2023.41.16_suppl.3554
Abstract #
3554
Poster Bd #
254
Abstract Disclosures
Similar Posters
Poster
2018 ASCO Annual Meeting
Outcomes of oxaliplatin-based (Ox) chemotherapy (CT) on R0 resection of colonic liver metastases (CLM).
First Author: Nicholas Adam Bosma
Poster
2016 Gastrointestinal Cancers Symposium
A single institute retrospective trial of concurrent chemotherapy with SIR-Sphere versus SIR-Sphere alone in patients with chemotherapy-resistant colorectal cancer liver metastases.
First Author: May Thet Cho
Poster
2024 ASCO Annual Meeting
REPROGRAM-02: A phase II-III study evaluating an induction treatment with regorafenib and metronomic chemotherapy before the second line chemotherapy in metastatic colorectal cancer.
First Author: Angelique Vienot
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Risk of relapse and patient selection for metastatic colorectal cancer liver surgery.
First Author: Madalena Machete